HPR25 Current Reimbursement Landscape for Re-Treatment with Anti-PD-(L)1 Agents after Treatment in Early-Stage Cancers: A Payer Survey
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.1095
https://www.valueinhealthjournal.com/article/S1098-3015(24)01210-5/fulltext
Title :
HPR25 Current Reimbursement Landscape for Re-Treatment with Anti-PD-(L)1 Agents after Treatment in Early-Stage Cancers: A Payer Survey
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01210-5&doi=10.1016/j.jval.2024.03.1095
First page :
Section Title :
Open access? :
No
Section Order :
10506